The cardiovascular protecting effects of resveratrol, an antioxidant polyphenol present in grapes and wine, have been attributed to its vasorelaxing effects and to its anti-inflammatory, antioxidant, and antiplatelet actions. Inhibition of adrenal catecholamine release has also been recently implicated in its cardioprotecting effects. Here, we have studied the effects of nanomolar concentrations of resveratrol on quantal single-vesicle catecholamine release in isolated bovine adrenal chromaffin cells. We have found that 30 to 300 nM concentrations of resveratrol blocked the acetylcholine (ACh) and high K ϩ -evoked quantal catecholamine release, amperometrically measured with a carbon fiber microelectrode. At these concentrations, resveratrol did not affect the whole-cell inward currents through nicotinic receptors or voltage-dependent sodium and calcium channels, neither the ACh-or K ϩ -elicited transients of cytosolic Ca 2ϩ . Blockade by nanomolar resveratrol of secretion in ionomycin-or digitonin-treated cells suggests an intracellular site of action beyond Ca 2ϩ -dependent exocytotic steps. The fact that nanomolar resveratrol augmented cGMP is consistent with the view that resveratrol could be blocking the quantal secretion of catecholamine through a nitric oxide-linked mechanism. Because this effect occurs at nanomolar concentrations, our data are relevant in the context of the low circulating levels of resveratrol found in moderate consumers of red wines, which could afford cardioprotection by mitigating the catecholamine surge occurring during stress.
Introduction
Increasing interest in the exploration of the pharmacological profile of resveratrol (3,4Ј,5-trihydroxystilbene), a compound present in grapes and wine, arose when it was associated to a putative cardiovascular protecting action. A number of large-scale epidemiological studies suggested that prolonged moderate consumption of red wine by Southern French and other Mediterranean populations was associated with a very low incidence of coronary heart disease, despite a high-fat diet, little exercise, and widespread smoking; this observation was coined as the French Paradox (Renaud and de Lorgeril, 1992) . The French Paradox hypothesis generated much interest in the study of the effects of resveratrol on various cardiovascular risk-like parameters. For instance, vessels precontracted with phenylephrine or K ϩ are relaxed by resveratrol (Chen and Pace-Asciak, 1996; Orallo et al., 2002) . The fact that resveratrol activates soluble and particulate guanylate cyclase and augments vascular cGMP levels suggests the involvement of the L-arginine-NO pathway. Prevention of nitric oxide (NO) degradation by inhibiting NAD(P) oxidase has also been linked to resveratrol (Orallo et al., 2002) . A direct protecting action on the heart through an NO-dependent mechanism has also been suggested previously (Hattori et al., 2002) ; such protection was associated to activation by resveratrol of a cGMP/protein kinase G path-way (Xi et al., 2009) . Anti-inflammatory, antioxidant, antiplatelet activity, and modulation of lipoprotein metabolism have also been associated with the cardiovascular protecting actions of resveratrol (Wu et al., 2001; Orallo et al., 2002; Bradamante et al., 2004) . Another high-risk cardiovascular factor is excessive levels of circulating catecholamines as a result of hyperactivation of the sympathoadrenal axis. This occurs as a compensatory mechanism taking place during cardiac failure as a consequence of an acute myocardial infarction (Kaye et al., 1995; Lymperopoulos et al., 2007) . In fact, blockers of ␤-adrenergic receptors are cardioprotective in this clinical setting and in myocardial infarction (Freemantle et al., 1999) . It is therefore surprising that the effects of resveratrol on catecholamine release have been approached only in two recent studies. In the first study, Shinohara et al. (2007) analyzed the release of catecholamine in primary cultures of bovine adrenal chromaffin cells elicited by acetylcholine (ACh), high potassium concentrations (K ϩ ), and veratridine; at micromolar concentrations, resveratrol blocked the responses to the three secretagogues. In a second study, Woo et al. (2008) explored the effects of resveratrol on catecholamine release from perfused rat adrenal glands stimulated with ACh, dimethylphenylpiperazinium, K ϩ , the muscarinic receptor agonist 4- [[[(3-chlorophenyl) amino]carbonyl] oxy]-N,N,N-trimethyl-2-butyn-1-aminium chloride (MCN-A-343), veratridine, cyclopiazonic acid, and 1,4-dihydro-2, 6-dimethyl-5-nitro-4-[2-(trifluoromethyl) phenyl]-3-pyridinecarboxylic acid, methyl ester (BayK8644), an activator of chromaffin cell L-type calcium channels (García et al., 1984) . The authors found that very high resveratrol concentrations (10 -100 M) reduced approximately 30 to 50% of the secretory responses elicited by 2-to 4-min perfusion of distinct secretagogues. In most studies trying to decipher the mechanisms involved in the putative cardioprotective effects of resveratrol, including those of Shinohara et al. (2007) and Woo et al. (2008) on adrenal catecholamine release, high concentrations (up to 100 M) of the polyphenol were used. Considering that only trace amounts of resveratrol have been found in plasma after its oral administration (Walle et al., 2004) , that orally administered resveratrol to humans is quickly metabolized into sulfate and glucuronic acid resveratrol-derivatives (Walle et al., 2004) ; and that after long-term consumption of moderate amounts of red wine, blood levels of resveratrol range from 100 to 1000 nM (Bertelli, 2006) , it follows that in vitro biological effects of micromolar resveratrol cannot explain the putative cardioprotective effects of moderate consumption of red wine. Here we have found that nanomolar concentrations of resveratrol caused a pronounced blockade of quantal catecholamine release from single bovine chromaffin cells stimulated with short ACh pulses. Because nanomolar resveratrol did not affect the wholecell inward currents flowing through nicotinic receptors (I ACh ), sodium channels (I Na ), or calcium channels (I Ca ), as well as the cytosolic Ca 2ϩ elevations ([Ca 2ϩ ] c ) produced by ACh or K ϩ , we favor the possibility that resveratrol is directly acting on the last Ca 2ϩ -independent steps of fusion pore formation and exocytosis through a mechanism similar to that produced by NO and NO donors, also described to take place in bovine chromaffin cells (Machado et al., 2000) .
Materials and Methods

Isolation and Culture of Adrenal Medulla Chromaffin Cells.
All experiments have been carried out in accordance with the Declaration of Helsinki and with the guide for care and use of laboratory animals as adopted and promulgated by the Universidad Autónoma de Madrid. Bovine adrenal medulla chromaffin cells were isolated according to standard methods with some modifications (Moro et al., 1990) . Cells were suspended in Dulbecco's modified Eagle's medium supplemented with 5% fetal calf serum, 10 M cytosine arabinoside, 10 M fluorodeoxyuridine, 50 IU/ml penicillin, and 50 g/ml streptomycin. For patch-clamp studies and single-cell measurement of catecholamine release, cells were plated on 13-mm diameter glass coverslips at low density (7.5 ϫ 10 4 cells/coverslip). To study the changes of [Ca] c , cells were plated at a density of 5 ϫ 10 5 cells/well in 25-mm six-well plates.
Amperometric Recordings of Single Vesicle Quantal Catecholamine Release. Amperometry was chosen to measure catecholamine release at the single cell level (Wightman et al., 1991) . Electrodes were built as described previously (Wightman et al., 1991) . The amperometer was homemade (Universidad Autónoma de Madrid workshop) and was connected to an interface (PowerLab/4SP; ADInstruments, New Zealand) that digitized the signal at 10 kHz sending it to an Apple Macintosh Power PC computer that displayed it within the Chart V. 4.2 software (ADInstruments, Dunedin, New Zealand). A 730-mV potential was applied to the electrode with respect to an AgCl ground electrode. The electrodes were calibrated according to good amperometric practices (Machado et al., 2008) by perfusing 50 M norepinephrine dissolved in standard Tyrode's solution and measuring the current elicited; only electrodes that yielded a current between 200 and 400 pA were used. At micromolar concentrations, resveratrol underwent some oxidation by the current passing through the carbon fiber microelectrode tip. This could lead to erroneous conclusions on the effects of resveratrol on the oxidation of catecholamine being released by the different secretagogues. To ascertain the extent of this interference, we recorded the amperometric current generated by a Tyrode's solution containing 50 M norepinephrine. We observed that after 5-min exposure of the carbon fiber to 300 nM resveratrol, the current generated by norepinephrine decreased by 29 Ϯ 4.4% (n ϭ 5 microelectrodes). Such interference amounted to 24.9 Ϯ 7.2% sensitivity loss after 5-min exposure to 100 nM resveratrol (n ϭ 7 electrodes). In the light of these data, and to minimize interference with amperometric detection of catecholamine release elicited by the various secretagogues, experiments were performed with resveratrol concentrations ranging between 30 and 300 nM resveratrol. Appropriate catecholamine standards were always used to test the variations in the electrode sensitivity. The coverslips were mounted in a chamber on a Nikon Diaphot inverted microscope (Nikon, Tokyo, Japan) used to localize the target cell, which was continuously superfused by means of a five-way superfusion system with a common outlet driven by electrically controlled valves, with a Tyrode's solution composed of 137 mM NaCl, 1 mM MgCl 2 , 5.3 mM KCl, 2 mM CaCl 2 , 10 mM HEPES, and 10 mM glucose, pH 7.3, NaOH. The high K ϩ solutions were prepared by replacing equiosmolar concentrations of NaCl with KCl. At the time of experiment performance, proper amounts of drug stock solutions were freshly dissolved into the Tyrode's solution.
Measurements of Whole-Cell Inward Currents. Ca 2ϩ (I Ca ), Na ϩ (I Na ), and ACh (I ACh ) currents were recorded using the wholecell configuration of the patch-clamp technique (Hamill et al., 1981) . Whole-cell recordings were made with fire-polished electrodes (resistance of 2-5 M⍀ when filled with the standard intracellular solutions) mounted on the head stage of an EPC-10 patch-clamp amplifier (HEKA, Lambrecht, Germany), allowing cancellation of capacitative transients and compensation of series resistance. Data were acquired with a sample frequency ranging between 5 and 10 kHz and filtered at 1 to 2 kHz. Recording traces with leak currents Ͼ100 pA or series resistance Ͼ20 M⍀ were discarded. Data acquisition and analysis were performed using PULSE programs (HEKA). Coverslips containing the cells were placed on an experimental chamber mounted on the stage of a Nikon Eclipse T2000 inverted microscope. During the preparation of the seal with the patch pipette, the chamber contained a control Tyrode's solution plus 5 M tetrodotoxin, pH 7.4 (no tetrodotoxin was added when measuring I Na or I ACh ). Once the patch membrane was ruptured and the whole-cell configuration of the patch-clamp technique had been established, the cell was locally, rapidly, and constantly superfused with an extracellular solution of similar composition to the chamber solution but containing nominally 0 mM Ca 2ϩ to measure I Na or 10 mM Ca 2ϩ to record I Ca (see Results for specific experimental protocols). For ionic current recordings, cells were dialyzed with an intracellular solution containing 100 mM CsCl, 14 mM EGTA, 20 mM TEA-Cl, 10 mM NaCl, 5 mM Mg-ATP, 0.3 mM Na-GTP, and 20 mM HEPES/CsOH, pH 7.3. The external solutions were rapidly exchanged using electronically driven miniature solenoid valves coupled to a multibarrel concentration-clamp device, the common outlet of which was placed within 100 m of the cell to be patched. The flow rate was 1 ml/min and regulated by gravity. Experiments were performed at room temperature (23-25°C).
Measurements of Changes in the Cytosolic Ca 2؉ Concentrations. The setup for fluorescence recordings was composed of a Nikon Diaphot 200 microscope and a Bio-Rad confocal unit (Bio-Rad Laboratories, Hemel Hempstead, UK) equipped with an oil immersion objective (Nikon 60ϫ Plan Apo; numerical aperture, 1.4). Chromaffin cells were loaded with 10 M concentration of the calcium probe fluo-4-acetoxymethyl ester for 45 min at 37°C as described previously (de Diego et al., 2008) . Sampling rate was 1 s during stimuli and 5 s for periods in between stimuli. A Tyrode external solution was used of the same composition as the one described above; concentrations of drugs added to this solution are indicated in the text.
cGMP Assay. Cells were plated onto 24-well dishes at a density of 5 ϫ 10 5 cells/well and maintained at 37°C in 5% CO 2 /95% air. Four days after isolation, chromaffin cells were preincubated with Tyrode's solution at 37°for 30 min. Then they were stimulated with agents in 0.3 ml of Tyrode's solution (with or without IBMX) for the indicated times. The reaction was stopped by the addition of 1% Triton X-100. Cells were scraped off of the wells, and the cGMP content was measured with a commercially available cGMP enzyme immunoassay kit (Sigma-Aldrich, St. Louis, MO) according to the instructions supplied by the manufacturer.
Reagents and Solutions. All reagents for the solutions were purchased from Sigma-Aldrich and Panreac Quimica (Barcelona, Spain). Dulbecco's modified Eagle's medium and penicillin-streptomycin were from Gibco (Carlsbad, CA), and bovine serum was from PAA Laboratories GmbH (Pasching, Austria). Fluo-4 was from Invitrogen (Carlsbad, CA).
Data Analysis and Statistics. Data analysis was carried out on a personal computer using Excel (Microsoft, Redmond, WA) and IgorPro (Wavemetrics, Lake Oswego OR). Amperometric charge (Q amp ) was calculated by integrating the amperometric current over time during the stimulus duration with a macro written in IgorPro. The number of spikes greater than 5 pA was manually counted on an extended graph displayed in the computer screen. A ruler was drawn at 5 pA, and spikes going above the threshold amplitude were considered. Differences between means of group data fitting a normal distribution were assessed by using either analysis of variance or Kruskal-Wallis test for comparison among multiple groups or Student's t test for comparison between two groups. p Ͻ 0.05 was taken as the limit of significance. A, example traces obtained in the same cell, generated by three sequential ACh pulses (P1, P2, and P3) applied at 5-min intervals. The pulses were applied with a Tyrode's solution containing 300 M ACh during a 3-s period. B, example traces obtained in the same cell showing a sandwich-type experiment consisting of an initial control ACh pulse (P1); then resveratrol was perifused for 4 min before and during application of P2. Finally, after 5-min washout, a third recovery pulse was applied (P3). C, pooled data from experiments performed with protocol A, showing the integrated cumulative secretion per pulse (Q amp , left ordinate) and spike number per pulse (right ordinate). D and E, averaged normalized secretion obtained with experiments performed with protocol B; data were normalized within each individual cell as a percentage of P1 both for cumulative secretion (left ordinate) and spike number (right ordinate). Data are means Ϯ S.E. of the number of cells shown in parentheses from one to three different cultures. ‫,ء‬ p Ͻ 0.05 compared with P1; #, p Ͻ 0.05 compared with P3.
Results
Quantal Catecholamine Release Responses Elicited by ACh: Effects of Resveratrol.
To measure the effects of resveratrol on Ca 2ϩ -dependent exocytosis triggered by various stimuli, we recoursed to single-cell recording of individual amperometric spikes, which are the result of quantal secretion of the catecholamine contents of individual chromaffin vesicles (Wightman et al., 1991) . The experiment began with the continuous local perifusion of the selected cell with a Tyrode's solution containing 2 mM Ca 2ϩ for approximately 1 min to obtain a stable baseline. Usually, no spontaneous amperometric spikes were detected. After baseline stabilization, the cell was challenged three successive times with 3-s duration pulses (P1, P2, P3), given with a solution containing 300 M ACh at 5-min intervals; this evokes sharp reproducible secretory responses. Figure 1A shows three spike traces obtained in an example cell. ACh promptly elicited a burst of quantal secretory spikes that lasted along the ACh pulse duration. In some cells, their secretory activity ceased before stopping ACh perifusion, whereas in others, such secretory activity lasted 1 to 2 s after ACh removal. In this particular cell, P1 generated a trace with pronounced baseline elevation as a result of large secretory activity and spike overlapping. This pattern was similar during P2 and P3. In other cells, baseline elevation was less pronounced (as in P1 of Fig. 1B ) or was even absent (as in P3 of Fig. 1B ). This sequential stimulation with ACh produced quite reproducible secretory responses when applied within the same cell, as illustrated in the bar graph of Fig. 1C ; total cumulative secretion (Q amp ) and number of spikes were similar in P1 and P2 and underwent a 20% decrease in P3, with respect to P1 and P2. This design permitted the exploration of the effects on secretion of different concentrations of resveratrol adopting a sandwich-type protocol, as that displayed in Fig. 1B in which the perifusion of 300 nM resveratrol practically abolished the ACh secretory response. This drastic effect was readily and fully reversible after washout of resveratrol, as indicated by the healthy response of Fig. 1B, P3 . Averaged results are given in the bar graph of Fig. 1E , indicating that 300 nM resveratrol inhibited by 80% both Q amp and spike number, with a practical full recovery of the response after 5 min of resveratrol washout. At 30 nM, resveratrol caused 23 Ϯ 8.7% inhibition of spike number (Fig. 1D) .
Inhibition by Resveratrol of ACh-Evoked Whole-Cell Inward Currents (I Ach ). At first glance, an obvious mechanism involved in the blockade by resveratrol of ACh-elicited secretion could be the inhibition of nicotinic receptors for ACh (nAChRs). Shinohara et al. (2007) have shown that resveratrol blocks I ACh in oocytes expressing ␣3␤4 nAChRs with an IC 50 of 25.9 M. We also tested the effects of resveratrol on I ACh but on native ␣3␤4 receptors of bovine chromaffin cells, voltage-clamped at Ϫ80 mV. Inward currents were evoked by repeated pulses of ACh. Such pulses (300 M, 0.5 s) produced peak I ACh that are highly reproducible when given at 30-s intervals for at least 15 min (data not shown). Figure 2A shows the time course of I ACh generated by sequential ACh pulses applied to an example cell. Note the initial current amplitude that was quite stable at approximately 1.7 nA. In other cells, the submicromolar concentrations of resveratrol that caused a drastic inhibition of secretion (i.e., 30-300 nM), however, did not touch I ACh (data not shown). Much higher concentrations of the compound caused a quick depression of I ACh that was gradually reversed upon its washout. The original I ACh traces shown in Fig. 2B were taken from the points labeled with small letters in Fig. 2A ; it seemed that at 30 or 100 M, resveratrol did not change the current kinetics. Figure 2C displays a concentration-response curve for the blockade of I ACh by resveratrol, with an IC 50 of 56 M, close to that found in oocytes expressing ␣3␤4 nAChRs, namely 25.9 M (Shinohara et al., 2007) . This indicates that resveratrol is approximately 600-fold less potent to block I ACh compared with its ability to inhibit ACh-evoked quantal secretion (Fig. 1) . As a consequence, these inhibitory effects of nanomolar concentrations of resveratrol cannot be attributed to its capacity to block nAChR currents at much higher concentrations.
Inhibition by Resveratrol of Whole-Cell Inward Currents through I Na . Chromaffin cells are depolarized by ACh that produces Na ϩ -dependent action potentials that will give rise to Ca 2ϩ -dependent release of catecholamines (de Diego et al., 2008; de Diego, 2010) . The possibility that resveratrol was acting on Na ϩ channels to block action potentials and secretion elicited by ACh was explored by measuring I Na in voltage-clamped cells subjected to repeated depolarizing pulses to 0 mV, given from a holding potential of Ϫ80 mV at 10-s intervals. Under these conditions, I Na amplitude remained stable for at least a 10-min period; I Na was fully blocked by 1 M tetrodotoxin (data not shown). Figure 3A shows the time course of I Na amplitude (peak current) in an example voltage-clamped cell. The initial I Na amplitude (approximately 1.2 nA) was mildly decreased in a step-wise manner by increasing concentrations of resveratrol (3-100 M). However, at 100 to 300 nM, resveratrol did not affect I Na (data not shown). Figure 3B shows original I Na traces taken from Fig. 3A at the points identified with lowercase letters; at 10 to 100 M, resveratrol did not change the current kinetics. Figure 3C shows a concentration-response curve for the inhibitory effects of resveratrol on I Na . Threshold blockade was achieved at 10 M, whereas maximal blockade at 100 M was only 25%. An IC 50 for this partial blockade was roughly estimated to be 25 M. Measuring 22 Na ϩ uptake elicited by ACh, Shinohara et al. (2007) (Douglas and Rubin, 1963) . Resveratrol could be blocking those channels and Ca 2ϩ entry, thereby causing inhibition of secretion. Thus, we decided to study the effects of nanomolar resveratrol on potassium-evoked quantal secretion. At 75 mM, K ϩ shifts the membrane potential of bovine chromaffin cells to near 0 (Orozco et al., 2006) , which will recruit all Ca 2ϩ channel subtypes, L, N, and P/Q, expressed by these cells ; thus, we chose this concentration of K ϩ to trigger the release of catecholamines and study the effects of resveratrol on this response. Figure 4A shows three secretory spike traces obtained from the same example cell that was sequentially challenged with 10-s duration pulses given at 5-min intervals with a solution containing 75 mM K ϩ /low Na ϩ (75K ϩ ). As in the case of ACh (Fig. 1A) , K ϩ rapidly produced a burst of secretory spikes that was quite reproducible during the three challenges. Unlike ACh, more cells exhibited a milder baseline elevation at the beginning of the traces (Fig. 4A) or no elevation at all (Fig. 4B ). This could explain that more individual secretory spikes were counted in the K ϩ traces (approximately 40-50 per stimulus; Fig. 4C ) compared with ACh traces (approxi- Fig. 3 . Partial blockade by resveratrol of the whole-cell inward sodium current (I Na ) through voltage-dependent sodium channels. Cells were voltage-clamped at holding potential of Ϫ80 mV. I Na was elicited by successive voltage depolarizing steps to 0 mV given at 10-s intervals. A, time course of I Na amplitude (peak current) in an example cell before (control) and upon cell perifusion with increasing concentrations of resveratrol, as indicated by the top horizontal bars. B, original I Na traces taken from the points labeled with lowercase letters in the time course curve shown in A. C, concentration-response curve of the inhibitory effect of resveratrol on I Na ; data are means Ϯ S.E. of six cells. Fig. 1C) . Measurements of integrated secretion per stimulus (Q amp ) and spike number in control conditions produced similar responses, as illustrated in the bar graph of Fig. 4C . This permitted the exploration of the effects of resveratrol on secretion using a sandwich type experimental protocol. Figure 4B shows an example cell in which 300 nM resveratrol caused a drastic inhibition of secretory events during P2, compared with the initial P1 response in the absence of the compound. Upon resveratrol washout, the cell secretory activity greatly recovered. Averaged normalized results indicated a concentration-dependent effect of resveratrol to block quantal secretion. Thus, at 30 nM, blockade was 25% (D), at 100 nM, 40% (E), and at 300 nM, 65% (F). Cumulative secretion and spike number were reduced to a similar extent.
Effects of Resveratrol on the Whole-Cell Inward Calcium Channel Currents through I Ca . As referenced above, the secretory response elicited by K ϩ pulses is due to augmented Ca 2ϩ entry through calcium channels. Thus, resveratrol could cause the blockade of K ϩ -elicited secretion by inhibiting the various subtypes of voltage-dependent calcium channels expressed by bovine chromaffin cells ). This possibility was tested by measuring the wholecell inward currents elicited by 50-ms test depolarizing pulses applied to cells voltage-clamped at Ϫ80 mV using 10 mM Ca 2ϩ as charge carrier. Figure 5A shows the time course of I Ca amplitude in an example cell being challenged with repeated test depolarizing pulses. The initial peak current was at approximately 900 pA. At the nanomolar concentrations used to study its effects on quantal release, resveratrol did not affect I Ca (data not shown). Resveratrol (10-30 M affected neither the current amplitude nor its kinetics (inset). Figure 5B shows I-V curves obtained before and in the presence of 30 M resveratrol. 
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There was no shift or inhibition of I Ca in the presence of these high concentrations of the compound. Therefore, it seems that resveratrol is inhibiting the K ϩ and the ACh-elicited exocytotic responses by a mechanism unrelated to Ca 2ϩ entry through calcium channels. 45 Ca 2ϩ influx into bovine chromaffin cells stimulated with ACh was inhibited by resveratrol with an IC 50 of 62.8 M (Shinohara et al., 2007) .
Effects of Resveratrol on the Elevations of [Ca 2؉ ] c Elicited by ACh or K
؉ Pulses. In chromaffin cells, exocytosis has an absolute requirement for Ca 2ϩ . Hence, we explored the possibility that resveratrol could affect the [Ca 2ϩ ] c elevations elicited upon challenging of the cells with ACh or K ϩ pulses, despite the fact that at nanomolar concentrations, the compound did not block either nAChR channels or voltage-dependent sodium and calcium channels. Figure 6A shows the [Ca 2ϩ ] c traces obtained in an example cell challenged with ACh pulses (300 M, 10 s) given at 5-min intervals. Four minutes before and during P2, 300 nM resveratrol was introduced. The compound produced by itself a rapid elevation of the [Ca 2ϩ ] c that decreased to baseline levels after 2.5 min of continued cell perifusion with resveratrol before P2 was applied. The presence of the compound did not alter the ACh-elicited [Ca 2ϩ ] c transient. Pooled results of these experiments are given in Fig. 6B ; note that at 300 nM, resveratrol itself produced a [Ca 2ϩ ] c elevation with an amplitude that was 50% of that of P1. However, the compound did not significantly modify the ACh-evoked [Ca 2ϩ ] c elevation. The nature of this transient [Ca 2ϩ ] c elevation elicited by nanomolar resveratrol is presently being studied in our laboratory. Similar experiments were done using three sequential K ϩ challenges (75 mM K ϩ , 10 s) given at 5-min intervals, as exemplified in the fluo-4-loaded cells of Fig. 6B . Averaged data are given in Fig. 6, C Because plasmalemmal ion channels seemed not to be involved in the mechanism underlying the drastic blockade of exocytosis by resveratrol, we further looked at a possible intracellular site of action of the compound by studying its effects on quantal catecholamine release responses triggered under experimental conditions that bypass plasmalemmal ion channels. Two such conditions were used, namely ionomycin and digitonin. Ionomycin is known to cause the release of catecholamines by a Ca 2ϩ -dependent mechanism but induces direct Ca 2ϩ entry into chromaffin cells without the intervention of Ca 2ϩ channels (Carvalho et al., 1982) . Figure 7A shows the continuous secretory activity of a cell that is being perifused with 10 M ionomycin. This pronounced activity remains constant for as long as a 10-min period, although at 8 to 10 min, secretion tended to decline (see averaged data in Fig. 7D ). In addition, the example cells of Fig. 7 , B and C, were continuously perifused with ionomycin. However, during the 2-to 4-and 6-to 8-min periods, 100 nM (B) or 300 nM (C) resveratrol was given on top of the ionophore. Secretion was rapidly and nearly fully inhibited during the time periods of resveratrol treatment; some spikes were visible during resveratrol treatment, particularly during the second treatment period. Averaged data on these inhibitory effects of resveratrol are given in Fig. 7 , E and F. The integral secretion in 2 min (Q amp ), and spike number was decreased by 70% with 100 nM (E) and 80 to 90% by 300 nM resveratrol (F). The second condition consisted in triggering quantal catecholamine release from digitonin-permeabilized cells. To perform this experiment, cells were first washed in a Ca 2ϩ -free Krebs-HEPES solution and resuspended in an intracellular solution of the following composition: 140 mM KCl, 3 mM MgCl 2 , 10 mM NaCl, 2 mM EGTA, 20 mM HEPES, 2 mM K 2 -ATP, and 1 mM KH 2 PO 4 , pH 7.1. Cells were placed in the microchamber and perifused with this same solution containing 2 M digitonin. Figure 8A shows an example amperometric spike record taken from a cell that was perifused with the intracellular solution deprived of Ca 2ϩ and containing 2 M digitonin. Secretion was triggered by introducing 30 to 50 M free [Ca 2ϩ ]. After a 7-s delay, the cell begun to fire amperometric secretory spikes that were initiated with a burst followed by continuous secretory activity with progressive decline at the end of the trace. In the trace shown in Fig. 8B , Ca 2ϩ was given in the presence of 300 nM resveratrol; an initial short-lasting spike burst was followed by spikes having lower amplitude and frequency compared with those obtained in the control cell (Fig. 8A) . Cumulative secretion (Q amp ) and spike number were calculated at 30-s intervals in each individual cell; they were averaged and plotted in Fig. 8, C and D, showing that resveratrol drastically diminished both parameters.
Effects of Resveratrol on the Levels of cGMP. NO donors cause a pronounced decrease of the amplitude of amperometric events and a slowing down of their kinetics through a mechanism dependent on guanylate cyclase and cGMP (Machado et al., 2000) . We therefore measured the levels of this cyclic nucleotide under conditions similar to those used to monitor the effects of resveratrol on quantal secretion evoked by ACh or K ϩ . Figure 9A shows that control cells had basal levels of cGMP of 1.5 fmol/10 6 cells. At 30 nM, resveratrol did not augment those levels. However, at 100 and 300 nM, resveratrol enhanced cGMP to approximately 2 and 3 fmol/10 6 cells. In cells incubated with phosphodiester- (Fig. 9B) , basal cGMP levels increased to 3 fmol/10 6 cells. This time, 30 nM resveratrol augmented those levels to 4.5 fmol/10 6 cells. Further increase was seen at 100 and 300 nM resveratrol (i.e., approximately 6 fmol/10 6 cells).
Discussion
Central to this study is the observation that nanomolar concentrations of resveratrol block the quantal single-vesicle release of catecholamine from individual chromaffin cells stimulated with short ACh or K ϩ pulses, as well as in ionomycin-or digitonin-treated cells. A priori, plasmalemmal nicotinic receptors, sodium channels, or calcium channels can be discarded to explain this secretion blockade because 100 to 300 nM resveratrol did not affect the ion currents flowing through those channels (Figs. 2, 3, and 5 ). This conclusion differs from that of Shinohara et al. (2007) , suggesting that resveratrol blocks bulk catecholamine release in bovine chromaffin cells incubated during 2 to 4 min with various secretagogues. Because they found a blockade also of 22 Na ϩ and 45 Ca 2ϩ uptake into cells incubated with veratridine, nicotine, or K ϩ , they suggested that secretion blockade was a result of sodium channel and calcium-channel blockade. Several differences could explain this discrepancy. First, we recorded I ACh , I Na , and I Ca , which is a more direct and reliable means of testing a drug effect on ion channel activity, at a much higher time resolution (milliseconds compared with minutes). Second, measurement of single-vesicle quantal catecholamine release in an isolated cell has much higher time resolution than secretion measured in minutes. Third, our stimulation pattern is closer to physiology (time range of milliseconds to few seconds). But the main difference between the study of Shinohara et al. (2007) and ours is the potency of resveratrol to block secretion; we found an extraordinary efficacy to block single-cell quantal catecholamine release at nanomolar concentrations. In contrast, Shinohara et al. (2007) found that resveratrol inhibits bulk secretion in cell populations stimulated with ACh with an IC 50 of 20.4 M. This striking difference may be due to measurement of quantal single-vesicle release in our study, with a time resolution in the more physiological millisecond time range.
In their study on perfused rat adrenals, Woo et al. (2008) also found that high resveratrol concentrations (10 -100 M) block bulk catecholamine release measured in 4-min periods. On the basis of experiments performed with BayK8644, these authors also suggest that resveratrol could be blocking the L-subtype of voltage-dependent calcium channels to inhibit secretion. Our results on direct I Ca measurements show that even at extremely high concentrations (i.e., 100 M, Fig. 5A ), resveratrol did not affect I Ca . The question now arises as to which mechanism could be involved in the blockade by nanomolar resveratrol of quantal catecholamine release.
We did not find a blocking effect of nanomolar concentrations of resveratrol on I ACh , I Na , and I Ca . This suggests an intracellular site of action to explain the blocking effects of resveratrol on single-vesicle quantal catecholamine release. The intracellular location of such a site is strongly supported by the experiment with ionomycin, a Ca 2ϩ -selective ionophore that causes Ca 2ϩ -dependent catecholamine release from adrenal glands (Carvalho et al., 1982) . This effect is not linked to plasmalemmal ion channels because the ionophore is incorporated into membranes and promotes Ca 2ϩ movement according to their electrochemical gradients (Carvalho et al., 1982) . The experiment on Ca 2ϩ -evoked catecholamine release from digitonin-permeabilized chromaffin cells (Fig.  8) , in which resveratrol elicited a pronounced blockade, also supports an intracellular site of action for the compound. Because resveratrol did not affect [Ca 2ϩ ] c elevations elicited by ACh and K ϩ , it seems that its effect must be linked to a Ca 2ϩ -independent step in the chain of events leading to membrane fusion and pore formation at the very last steps of exocytosis.
Cardiovascular protection has been linked to the L-arginine-NO synthase signaling pathway; this is so because resveratrol augments the activities of soluble and particulate guanylate cyclase, thereby increasing cGMP levels in vascular tissues (Orallo et al., 2002) and in chromaffin cells (this study). Thus, blockade by resveratrol of quantal release could be mediated by cGMP, although the role of this nucleotide in regulating catecholamine release is controversial. For instance, O'Sullivan and Burgoyne (1990) found that NO donors augmented catecholamine release. Others found inhibition of secretion (Oset-Gasque et al., 1994; Rodriguez-Pascual et al., 1996) . Augmentation by resveratrol of cGMP levels in chromaffin cells (Fig. 9 ) and inhibition of quantal secretion fit well in the frame of the hypothesis raised by Borges' laboratory that the activation with NO donors of the NO-guanylate cyclase-cGMP pathway will block catecholamine release by changing the affinity of the intravesicular matrix for catecholamines (Machado et al., 2000) . Resveratrol has been shown to augment the circulating levels of NO (Hung et al., 2000) and the expression of endothelial nitricoxide synthase and inducible nitric-oxide synthase in mice (Das et al., 2005) . On the other hand, when given in drinking water, resveratrol offered ex vivo cardioprotection through a mechanism dependent on both NO and adenosine (Bradamante et al., 2003) .
The relevance of nanomolar concentrations of resveratrol in blocking the quantal catecholamine release deserves a pharmacokinetic comment. For instance, after long-term consumption of moderate amounts of red wine containing a known concentration of resveratrol, its blood levels range from 100 nM to 1 M (Bertelli, 2006) . A detailed study in humans demonstrated that absorption after oral administration of resveratrol is very high, but only trace resveratrol concentrations in plasma were detected; the bulk of resveratrol was quickly metabolized into sulfate and glucuronic acid resveratrol derivatives or hydrogenation of the aliphatic double bond (Walle et al., 2004; Wenzel and Somoza, 2005) . These low circulating levels of resveratrol cast doubts on extrapolation to humans or to in vivo animal models of disease, of the collection of biological effects of resveratrol found in vitro, that most of them required resveratrol concentrations in the range of 10 to 100 M and even greater. However, some biological activities relevant to its putative cardioprotective effects in humans, have been described to occur in the nanomolar to 1 M range of resveratrol concentrations. This is the case for its antiplatelet activity seen at 1 M (Bertelli et al., 1996) or protection by 1 M resveratrol against cold preservation-warm reperfusion damage (Plin et al., 2005) . In this context, our present study shows unequivocally that 30 to 300 nM resveratrol causes an efficient and potent blockade of the quantal catecholamine release triggered by various secretagogues in chromaffin cells. This could notably contribute to the cardioprotective effects of resveratrol that have been intensely explored during the last two decades (Pervaiz, Orallo, 2006 Orallo, , 2008 Bertelli, 2007; Harikumar and Aggarwal, 2008; Pirola and Fröjdö, 2008) .
In conclusion, we have shown that nanomolar resveratrol blocks quantal catecholamine release from single chromaffin cells stimulated with various physiological and nonphysiological secretagogues. Such an effect occurs at the very last Ca 2ϩ -independent step of exocytosis and is mediated by the NO-cGMP pathway. These findings gain clinical relevance when considering that the effects of resveratrol occur at nanomolar concentrations, which can be reached in plasma after moderate consumption of red wine. They can contribute to a better understanding of the French Paradox and of the potential cardiovascular protection afforded by wine resveratrol. Mitigation by this polyphenol of the sympathoadrenal stress response could alleviate the potent arrhythmogenic effects of circulating catecholamines, which are drastically increased during stressful conflicts taking place during daily living.
